Moderna (MRNA) EBITDA US GAAP (year values) |
|||||||||
2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
EBITDA, bln rub | ? | -732.0 | 13 528 | 9 923 | 9 768 | -3 283 | -2 217 | ||
Changes by years, y/y, % | +42% | -1 948% | -27% | -2% | -134% | +51.4% |
Moderna. EBITDA US GAAP, bln rub
Moderna. EBITDA US GAAP, changes, %
Moderna. EBITDA US GAAP, sum by quarters, bln rub
Moderna (MRNA) EBITDA US GAAP (quarter values) |
||||||||
2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
EBITDA, bln rub | ? | -1 699 | 208.0 | -1 123 | -1 232 | -70.0 | -2 217 | |
Changes by years, y/y, % | -227% | -87% | +290% | -31% | -96% | |||
Changes by quarters, q/q, % | -16% | -112% | -640% | +10% | -94% |